We report for the first time inactivation of a tissue-specific Bcl-2 homology domain 3 (BH3)-only protein as a common aspect in human cancer. In detail, we show that loss of the BH3-only protein natural born killer (Nbk)/Bcl-2-interacting killer (Bik) is a common feature of clear-cell renal cell carcinoma (RCC). While strong Nbk expression is found in the renal tubuli and the epithelial lining of the glomerula, a consistent loss of Nbk expression was observed in primary RCC tissue and RCC cell lines. Mutation of Nbk is, however, rare, whereas deletion of the Nbk gene at 22q13.2 is frequent. In addition to loss of heterozygosity (LOH), DNA methylation mediates transcriptional silencing of the Nbk gene. The conditional restoration of Nbk/Bik expression led to apoptotic death of RCC but not of nonmalignant renal epithelia. A broader expression analysis of RCC cell lines for BH3-only proteins revealed that loss of Nbk coincides with failure to express Bim, whereas Puma, Bid and BNIP3 are readily detectable and, in case of Puma, inducible by p53. These data delineate a role for defects in BH3-only proteins as tumor suppressors in RCC and may explain at the same time the impressive clinical apoptosis resistance of RCC.
Introduction
The Bcl-2 family of proteins and its opposing groups of antiand proapoptotic members arbitrate life-or-death decisions. The apoptosis-promoting members of the Bcl-2 family can be subdivided into the multi-Bcl-2-homology (BH) domain members Bax, Bak, Bok and the growing subfamily of proteins sharing only the BH3 domain. 1 The emerging function of these 'BH3-only' proteins appears to provide a link between various cell death sensors and the execution machinery of apoptosis. 2 Thus, BH3-only proteins may function as death sensors that mediate activation of the mitochondrial apoptosis pathway in response to, for example, oncogenic stress signals or DNA damage. For example, Noxa and Puma are transcriptionally induced by p53 and mediate apoptosis induced by p53. 3 These proapoptotic activities of certain BH3-only proteins essentially depend on the presence of Bax and Bak. Additional findings indicate that some BH3-only proteins can promote apoptosis by two mutually nonexclusive mechanisms: by directly inactivating prosurvival Bcl-2 proteins or through direct or indirect modification of Bax-like molecules. [4] [5] [6] For some BH3-only proteins, including natural born killer (Nbk) and Puma, an entirely Bax-dependent mode of action was recently established, [7] [8] [9] whereas others may act through the activation of Bak. 7 Loss of Bax is a frequent event in human cancer and may be associated with poor prognosis and clinical resistance to anticancer therapy. 10, 11 Moreover, loss of the Bax gene was shown to contribute to oncogenic transformation 12 and tumor development in BaxÀ/À mice. 13 Thus, not only deregulated expression of antiapoptotic Bcl-2 but also disruption of proapoptotic Bcl-2 homologs is critically involved in tumorigenesis. In contrast, far less information is available regarding the consequences of BH3-only gene defects.
Various knockout mouse models have recently implicated loss of several BH3-only proteins in tumorigenesis. Published data show that targeted knockout of Bad facilitates development of high-grade lymphoma and that disruption of Bim accelerates lymphomagenesis in the Em-myc model. 14 There, loss of Bim alleviates the need for inactivation of the p53/ p14 ARF pathway during lymphomagenesis. 15 Disruption of Bid results in late-onset chronic myelomonocytic leukemia. 16 This delineates the importance of BH3-only proteins in tumor surveillance. Nevertheless, a link between human disease and BH3-only protein deficiency could not be established so far. Here, we show for the first time that disruption of a specific BH3-only protein is a common feature in a human cancer. Renal cell carcinoma (RCC) exhibit loss of Nbk and reexpression of Nbk triggers apoptotic death in RCC cells. Given the tissue-specific expression of Nbk with highest expression in renal cell epithelia, Nbk might therefore act as a renal tissue-specific tumor suppressor gene. This is supported by the observation that Nbk is a target of p53 17 and has been implicated in the response to DNA damage-induced cell death. 18 Loss of Nbk might therefore explain the impressive intrinsic resistance of RCC towards apoptosis induction.
Results
Normal kidney epithelia exhibit high expression of Nbk protein in the renal tubuli and the epithelial lining of the glomerula (Figure 1a) . In contrast, surrounding connective tissues, mesangial cells of the glomerula and blood vessels do not express Nbk. Nbk expression is tissue specific and high expression is found only in the kidney 19 and the involuting breast. 20 To investigate whether Nbk is a potential tumor suppressor, we studied Nbk expression, deletion and mutation in primary RCC carcinoma samples as compared with nonmalignant renal epithelia. In contrast to nonmalignant tissue that showed high expression of Nbk protein, a consistently weak expression or complete loss of Nbk was seen in all 57 clear-cell RCC studied (Figure 1 ). Similar data were obtained by the use of both antibodies against the N-or the C-terminus of Nbk. A direct comparison of normal renal tissue with cancer tissue on the same tissue slide was feasible in 28 patients. There, decrease of Nbk expression in RCC proved to be highly significant (Wilcoxon's signed-rank test, Po0.0001, Figure 1b) . Clinicopathological data are listed in Table 1 . Loss of Nbk/Bik protein expression was a general feature of the RCC tumors and did not correlate with the presence or absence of distant metastases, tumor grading, tumor size or involvement of lymph nodes (w 2 test, P40.1). To clarify the mechanism of Nbk loss, we analyzed Nbk protein and RNA expression in RCC lines. In accordance with the immunohistochemistry data, Western blot analyses for Nbk expression in RCC cell lines showed low or absent protein expression. In nine of the 10 RCC cell lines analyzed, Figure 2 ). To study whether loss of Nbk coincides with a general loss of BH3-only expression, we performed mRNA expression profiling in the Caki-2 line following induction with 5 0 aza-2 0 dC ( Table 2) . Expression of multidomain proapoptotic Bcl-2 homolog Bax and Bak mRNA was unaffected following 5 0 aza-2 0 dC treatment. Expression of the ovarian-specific Bax/Bak homolog Bok was below the detection limit. Analysis of BH3-only mRNA expression confirmed that loss of Nbk occurs at the mRNA level, that is, through a transcriptional mechanism. Notably, we found other BH3-only proteins to be expressed at low, marginally detectable levels: Bim, Noxa, harakiri (Hrk) and Bad. In contrast, Puma, Bid and BNIP3 were readily detectable. Exposure to 5 0 aza-2 0 dC resulted in strong upregulation of Nbk mRNA. Likewise, Bim expression was induced upon demethylation treatment, but remained below the cutoff for significant expression (absolute call 'absent'). To corroborate these data, Nbk mRNA was measured by quantitative real-time PCR. In fact, exposure to 5 0 aza-2 0 dC resulted in a 7.470.8-fold induction of Nbk mRNA expression (Figure 3 ). In accordance with the DNA array data, mRNA expression levels of all other BH3-only mRNAs and the multidomain proteins Bax, Bak and Bok remained unaffected.
Notably, one of the RCC lines, RCC-MF, showed no Nbk/ Bik-expression upon 5 0 aza-2 0 dC treatment ( Figure 2 ). To further address this phenomenon and the mechanism of Nbk loss in RCC, chromosomal deletions affecting the NBK locus were analyzed by interphase FISH. Four of the cell lines including RCC-MF exhibited interphase FISH signal patterns suggesting loss of the NBK/BIK gene locus at 22q13.2. Surprisingly, Caki-2 cells showed a signal pattern suggesting gain of the NBK gene locus. Nevertheless, Caki-2 exhibits rather low constitutive Nbk protein expression that is, however, strongly increased upon demethylation. Together with the protein and RNA expression data (Figures 2 and 3 ), these FISH analyses indicate that chromosomal losses of the NBK/BIK gene locus contribute to the loss of Nbk expression. CIP/WAF-1 showed constitutive high expression and Caki-2 showed no inducible p21 expression at all, indicative of a general defect in p53 signaling as described earlier for other RCC cells. 21 In RCC-MF, weak Nbk expression was induced by ectopic adenoviral p53 expression (Figure 4 ), corroborating that Nbk is a p53-inducible gene. Notably, no Nbk induction was observed in the six other RCC lines tested. Likewise, constitutive, noninducible expression of Bim EL and Bim L (but not of Bim S ) was found in RCC-MF, while all other lines lacked Bim expression. In contrast, Puma was readily detectable and the expression followed a similar pattern as that of p21 CIP/WAF-1 upon enforced expression of wild-type p53. Thus, loss of Nbk coincides with a selective failure to express Bim protein (and possibly Noxa, Hrk and Bad as well), whereas Puma protein is expressed both constitutively and in a p53-inducible manner.
To further explore the mechanism of Nbk inactivation, we screened for Nbk mutations in 57 tumor samples and in the RCC lines. Single-strand conformation polymorphism (SSCP) PCR and sequencing were informative in 52/57 tumors and revealed two aberrations. A monoallelic single-nucleotide polymorphism (SNP) leading to an amino-acid exchange at codon 26 (ACC to ATC, threonin to isoleucin) was found in three primary tumors and in the cell line RCC-LR. Furthermore, 48/52 tumors expressed an intronic CT deletion within the polypyrimidine tract upstream of the 3 0 splice at the intron 3/exon 4 boundary as compared with the Nbk gene database entries ( Figure 5 ). The CT deletion was homozygous in 23/52 tumors and heterozygous in 25/52 tumors. Mono-or biallelic CT deletions showed, however, no differences in the level of residual Nbk/Bik-protein expression between these RCC To address the functional consequences of Nbk loss, we aimed to reconstitute Nbk expression. Efforts to stably reexpress Nbk in the RCC cell lines were not successful and we therefore established a single-vector conditional adenoviral expression system that carries Nbk under the control of the Tet-off expression system and has a 100% transduction efficacy at low multiplicities of infection. This vector provides the tetracycline-responsive transactivator in cis and is switched off in the presence of doxycyclin. 9 When this vector was employed for Nbk expression in the absence of doxycyclin, RCC cells released cytochrome c and underwent caspase-3 activation (Figure 6 ). This was accompanied by execution of apoptosis as determined by measurement of genomic DNA fragmentation on the single-cell level in RCC cells (Figure 7a ). In contrast, nonmalignant renal epithelial cells were protected from Nbk-induced apoptosis (Figure 7b ). Induction of apoptosis was associated with dissipation of the mitochondrial membrane potential in the RCC cells, but not in the nonmalignant renal cells. This indicates that reconstitution of Nbk initiates the mitochondrial apoptosis pathway in RCC cells. Moreover, sensitivity to apoptosis induced by Nbk seems to be restricted to malignant cells, but not nonmalignant renal epithelial cells. Thus, loss of Nbk is critical to maintain the viability of RCC cells and this indirectly suggests that Nbk may act as a tumor suppressor gene in RCC. 
Discussion
BH3-only proteins are structurally distinct members of the Bcl-2 family. Unlike the multidomain proapoptotic proteins Bax and Bak, they possess only one of the BH signature domains, a nine-amino-acid stretch termed BH3 region. 22 Various studies have shown that these proteins are essential initiators of programmed cell death in species as distantly related as mice and Caenorhabditis elegans. Structural and functional analyses have demonstrated that the BH3 domain is required for their ability to bind to Bcl-2-like prosurvival proteins and to initiate apoptosis. 5, 23, 24 BH3-only proteins mediate cell death through the induction of a conformational switch in Bax 9,25 or Bak. 26, 27 This is associated with the redistribution of Bax from the cytoplasm to membranes of cellular organelles including the mitochondria. There, Bax and Bak oligomerize and mediate the release of cytochrome c and other apoptogenic factors into the cytosol. This ultimately leads to the activation of the caspase cascade and other protease systems that execute the final stages of apoptosis and the demise of the cell. 1 Genetic studies in mice and human tumors established that loss of Bax and Bak renders cells refractory to BH3-only protein-induced apoptosis. 4, 8, 9 Interestingly, BH3-only proteins link various upstream signals including the p53 pathway and oncogene-driven cell death to the intrinsic apoptosis pathway. Mutations in BH3-only proteins were therefore suggested to be pathogenic in human cancer. 22 So far there is, however, only scarce evidence for this hypothesis. Data from knockout mice indicate that loss of Bad or Bim may facilitate lymphomagenesis. No such data are available regarding human tumors. Here, we report for the first time that disruption of a tissuespecific BH3-only protein is a general principle in a human cancer, clear-cell RCC. The tissue-specific expression pattern of Nbk with high expression found only in the kidney 19 or the involuting mammary gland 20 prompted us to investigate Nbk expression in RCC. There, we observed loss of Nbk expression as compared to nonmalignant renal epithelia. The failure to express Nbk is apparently due to both genomic deletion and transcriptional silencing by hypermethylation, whereas NBK gene mutation does not appear to represent a major mechanism. In RCC lines, deletion of the NBK gene at 22q13.2 was observed in four of 10 cell lines. Thus, similar to other tumor suppressor genes, transcriptional silencing may represent a key step to silence the second allele in case of LOH. Loss of Nbk was a common feature of all RCC tumors and cell lines studied, and was not related to metastatic disease, lymph node infiltration, grading or tumor size. Thus, loss of Nbk represents a unifying genetic event that might play a critical role in tumorigenesis, but less likely in tumor progression and associated secondary genetic events. Moreover, we provide evidence that loss of Nbk coincides with lack of Bim, but not of Puma protein expression. Expression profiling furthermore suggests that this lack of Nbk and Bim expression coincides with lack of Noxa, Hrk and Bad. Lack of both Bim protein and mRNA expression indicated that Bim might be lost through a similar mechanism as Nbk, that is, as a consequence of gene methylation. This is, at least in Caki-2, not supported by real-time PCR analyses that failed to detect a significant increase in mRNA expression of Bim and other BH3-only factors or multidomain Bcl-2 homologs Bax, Bak and Bok following DNA-demethylating treatment by use of 5 0 aza-2 0 dC. The reason for the failure to express some but not all BH3-only proteins remains enigmatic, but nevertheless suggests that Puma and other BH3-only proteins including Bid and BNIP3 do not follow the same pattern of epigenetic regulation in malignant tumors. This has important implications for anticancer therapies that rely on Puma, 3 such as ionizing irradiation or some anticancer drugs. In fact, Puma was inducible following induction by p53, indicating that this part of the p53 signaling axis is intact in RCC. Likewise, the use of the death ligand TRAIL alone 28 or in combination with DNA-damaging anticancer therapies critically depends on the BH3-only protein Bid for transduction of the cell death signal, 29, 30 and this part of TRAIL signaling should remain operative in RCC.
Notably, restoration of Nbk expression resulted in apoptotic death of RCC cells, whereas nonmalignant renal epithelial cells displayed a significant resistance towards Nbk reexpression. This supports the notion that Nbk acts as tumor suppressor. Moreover, Nbk was shown to be a transcriptional target of p53 17 and to act in the DNA damage response pathway. 18 Thus, disruption of Nbk appears to represent an important event in the selection process leading to the impressive resistance to apoptosis and anticancer therapy usually observed in RCC. Nonetheless, knockout mice for Blk, a putative murine Nbk homolog, so far lack a phenotype. This may point out that like in the case of Bcl-2 overexpression, additional genetic events are required apart from Nbk loss to facilitate oncogenesis. 31 So far, the reasons for the distinct sensitivity of the malignant versus the nonmalignant renal cells remain enigmatic. An underlying mechanism could reside in the higher expression of antiapoptotic Bcl-2 family members such as Bcl-2 or Bcl-x L that are known to interfere with Nbk-induced apoptosis. Alternatively, Nbk might be counteracted by so far undefined inhibitor in normal cells as compared with carcinoma. In addition, post-translational modification of Nbk has been described and this might affect the function of Nbk in the normal renal epithelial cells, albeit physiological stress stimuli seem to induce Nbk at the transcriptional level. 20 Apart from the tissue-specific BH3-only protein Nbk, expression of additional BH3-only proteins is affected in RCC. Specifically, a panel of RCC lines failed to express Bim protein, whereas the p53 target Puma was inducible upon ectopic p53 expression. Thus, the impressive apoptosis resistance of RCC cells may arise from an additive defect to express BH3-only proteins that may synergize with Nbk as recently shown for Nbk and Noxa. 32 While two of these BH3-only proteins, Nbk and Noxa, act within the p53 signaling cascade, Bim is in general not recognized as a p53-inducible gene. Nevertheless, ionizing irradiation has been described to induce Bim expression through a p53-controlled mechanism. 33 Thus, combined loss of BH3-only proteins may not only result in resistance to therapy and tumor progression, but may contribute to the general disruption of p53 signaling in RCC. 21 Finally, our finding that Nbk -similar to other proapoptotic and cell cycle inhibitory genes -is lost as a consequence of epigenetic silencing offers the potential for therapeutic intervention, for example, by interfering with DNA methylation and histone acetylation. Apart from directly inducing cell death through such remodeling of the transcriptome, a practical approach might reside in the enhancement of chemosensitivity upon re-expression of Nbk by such strategies. 18 
Materials and Methods

Clinical samples and immunohistochemistry
Immunohistochemistry of paraffin-embedded tissue specimen was performed as described 34 by the use of polyclonal goat anti-Nbk antibody (N-19 or C20; Santa Cruz, CA, USA). RCC samples from 57 patients were analyzed. In 28 patients, nonmalignant renal tissue was available. Clinicopathological characteristics are given in Table 1 . Analysis of slides was carried out in a blind manner, without the knowledge of clinicopathological data. Four high-power fields ( Â 400) were evaluated for localization and percentage of positive cells (0-100%). Staining intensities were graded between 0 (negative) and 3 (strong expression). Staining indices were calculated by multiplying percentages of positive cells and staining intensities as described. 35 Cell culture RCC cell lines were obtained from CLS (Heidelberg, Germany). Cells were grown in RPMI 1640 supplemented with 10% FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin (GIBCO-Invitrogen, Karlsruhe, Germany). For treatment with 5 0 aza-2 0 dC, cells were plated on day 0 and were treated with 5 0 aza-2 0 dC (Sigma-Aldrich, Deisenhofen, Germany) at 1 mM on days 2 and 4 and harvested on day 7. Adenoviral overexpression of Nbk 9,36 or p53 37 was performed as described.
Detection of apoptotic cell death
Apoptosis was determined on the single-cell level by flow cytometric analysis measuring the DNA content of individual cells. In brief, cells were fixed on ice in 1% formaldehyde followed by 70% ethanol and subsequent treatment with RNAse. Cells were stained with propidium iodide and cellular DNA content was determined as described. 9 Data are given as the percentage of hypodiploid (sub-G1) cells, that is, cells displaying apoptotic DNA fragmentation. Breakdown of mitochondrial membrane potential was determined by the use of the cationic dye JC-1 as described. 9 
Western blot analysis
Immunoblotting was performed as described. 9 Primary antibodies were polyclonal goat anti-Nbk antibody (N-19) and anti-Puma-a against epitopes mapping at the N-termini of the human proteins (N-19) and were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Other antibodies were as follows: monoclonal mouse anti-human cytochrome c (clone 7H8.2C12; BD Biosciences Pharmingen, San Diego, CA, USA), polyclonal goat anti-human caspase-3 (R&D Systems, Wiesbaden-Nordenstadt, Germany) and polyclonal rabbit anti-Bim (raised against a peptide corresponding to amino acids 22-40 of human and mouse Bim). Murine monoclonal antibodies against p21 CIP/WAF-1 (clone 6B6, raised against a fusion protein between GST and full-length human p21) and p53 (clone DO-1, reactive against amino acids 1-45 of human p53) were purchased from BD-Pharmingen (Heidelberg, Germany). Secondary anti-goat and anti-mouse horseradish peroxidase-conjugated antibodies were from Promega (Mannheim, Germany) or Southern Biotechnology Associates (Birmingham, AL, USA). Bands were visualized by means of the enhanced chemiluminescence system and exposed to Hyperfilm (both Amersham-Buchler, Braunschweig, Germany).
Analysis of Nbk RNA expression and DNA mutation RNA extraction and semiquantitative RT-PCR were performed according to standard procedures. 38 For quantitative real-time PCR, 250 ng of total RNA was reverse transcribed. PCR was performed using the ABI Prism 7000 sequence detection system (Applied Biosystems, Weiterstadt, Germany). The relative amounts of specifically amplified cDNA were calculated using 18S rRNA as an internal reference. All reactions were carried out in triplicate. Primers and probes for Nbk/Bik and other Bcl-2 homologs were crosschecked via the ensembl.org home page of the EMBL-EBI and the Sanger Institute. For mutation analyses, DNA was extracted from paraffin-embedded tissue or cultured cells as described. 10 Coding exons 2-5 of Nbk/Bik were amplified using intronic primers according to the NCBI nucleotide database (www.ncbi.nlm.nih.gov/), accession numbers AL022237.1, AF174421.1, AF174422.1, AF174431.1 and AF174441.1. Genomic PCR and SSCP analyses were performed as described. 10 PCR products with aberrant SSCP pattern were sequenced by use of BigDye terminator cycle sequencing on an ABI Prism 310 sequencer (PE Applied Biosystems, Weiterstadt, Germany), using the primers employed for PCR amplification. For primer sequences see Table 3 .
Oligonucleotide array analysis RNA preparation, cDNA synthesis and labeling and U133A DNA oligonucleotide array (Affymetrix, Santa Clara, USA) hybridization were performed as described. 39 Hybridization, washing and staining were performed according to the standard Affymetrix protocol. Data analysis was performed by use of the Microarray Suite software (Affymetrix).
Fluorescence in situ hybridization
Using bioinformatic resources (http://genome.ucsc.edu), clones RP3-323M22 (centromeric), CTB-1191B2 (spanning) and RP3-526I14 (telomeric) were selected as FISH probes for the NBK/BIK locus at 22q13.2. The cosmid clone 91c (AC000091) containing the TBX1 gene at 22q11.2 served as internal control. The differently labeled flanking probes were pooled to obtain a break-apart assay for the detection of breakpoints; the differently labeled clones CTB-1191B2 and 91c were pooled to investigate genomic imbalances affecting the NBK/BIK locus. The triple color probe set CEPX/CEPY/CEP18 (Vysis) was applied to study ploidy. Sample preparation, denaturation, hybridisation, washings and counterstaining followed the standard protocols. TTA GGG GTC CAG TCA TAT GC  55  253  2  Antisense  CCT GAA GTC ACT ATC AGG CA  3  Sense  CGG CAC AGC CAC ACC CGA CT  57  169  3  Antisense  TGT AGA GGC ATA GGG CAT AG  4  Sense  CTC CTG CAG TAA TGG CTT TGT C  60  202  4  Antisense  TCA GGG TCA GGG ATC TCA AGG C  5  Sense  CTG CCC CGA GCC TGA CTC C  67  174  5  Antisense  TGG TCA TGG GGG TGG 
